Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new 'Study Status' entry is added to the Record History, and a new version entry (version 29) appears, reflecting updated status-tracking on the study's history page.
    Difference
    0.3%
    Check dated 2026-05-07T22:09:34.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry, v3.5.3, replacing the previous v3.5.2 and signifying an updated version of the record.
    Difference
    0.1%
    Check dated 2026-04-30T16:48:02.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new Study Status entry on 2026-04-03 for revision v3.5.2. Removed the older v3.5.0 revision on 2026-03-02.
    Difference
    0.4%
    Check dated 2026-04-16T10:31:00.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the history. The previous revision v3.4.3 was removed from the list.
    Difference
    0.1%
    Check dated 2026-03-25T20:33:59.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision log updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:51:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The Record History page now includes a Study Status section with new entries on 2026-02-27 and 2026-03-02. The 2026-01-26 entry was removed.
    Difference
    0.3%
    Check dated 2026-03-04T09:11:23.000Z thumbnail image

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.